Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sumit Aggarwal currently holds 60,000 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sumit Aggarwal has been a net neutral trader of ELOX stock. They have purchased $0 and sold $0 worth of shares.
Sumit Aggarwal's most recent insider trade was on Jan 24, 2024, when they sold 60,000 shares at $0.00 per share.
Sumit Aggarwal serves as Executive at Eloxx Pharmaceuticals, Inc. (ELOX). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Sumit Aggarwal holds the position of Executive at Eloxx Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Sumit Aggarwal has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sumit Aggarwal was on Dec 1, 2021, when they sold $59.0K worth of ELOX shares. This transaction involved 81,933 shares at $0.72 per share.
Sumit Aggarwal currently owns 60,000 shares of Eloxx Pharmaceuticals, Inc. (ELOX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sumit Aggarwal's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sumit Aggarwal has 3 Form 4 filings on record as an insider at Eloxx Pharmaceuticals, Inc..
Set alerts for Sumit Aggarwal and 40,000+ other insiders.